Arrowhead Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Arrowhead Pharmaceuticals

10/02/2025 22:01

* Arrowhead Pharmaceuticals Inc  ARWR.OQ  reported a
quarterly
adjusted loss of $1.39​​ per share for the quarter ended
December 31, lower than the same quarter last year, when the
company reported EPS of $-1.24.  The mean expectation of
fourteen analysts for the quarter was for a loss of 44 cents per
share. Wall Street expected results to range from $-1.43
to $2.91 per share.
    * Revenue fell 29.6% to $2.50 million from a year ago;
analysts
expected $65.48 million. 
    * Arrowhead Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of $1.39​.
    * The company reported a quarterly loss of $173.09 million.
    * Arrowhead Pharmaceuticals Inc shares had risen by 7.7%
this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 65.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 5
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Arrowhead
Pharmaceuticals Inc is $45.50 
This summary was machine generated from LSEG data February 10 at
10:01 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2024      -0.44          -1.39          Missed
 Sep. 30 2024      -1.05          -1.37          Missed
 Jun. 30 2024      -0.55          -1.38          Missed
 Mar. 31 2024      -0.16          -1.02          Missed